Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Week, Multicenter, Open-Label Study to Evaluate the Effectiveness and Safety of Donepezil Hydrochloride (Aricept) in Hispanic Patients With Mild to Moderate Alzheimer's Disease

NCT00230568 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00230568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00230568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Week, Multicenter, Open-Label Study to Evaluate the Effectiveness and Safety of Donepezil Hydrochloride (Aricept) in Hispanic Patients With Mild to Moderate Alzheimer's Disease
Lead sponsor
Eisai Inc.
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2005
Completion date
December 31, 2007
Enrollment
100 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease